{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:59:53Z","timestamp":1790758793542,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.neurol.2011.06.005","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T21:53:27Z","timestamp":1321566807000},"page":"33-39","source":"Crossref","is-referenced-by-count":11,"title":["\u00c9v\u00e8nements neurologiques sous traitement par anti-TNF alpha"],"prefix":"10.1016","volume":"168","author":[{"given":"M.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Baldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lebrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neurol.2011.06.005_bib0005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMoa011341","article-title":"A longitudinal study of abnormalities on MRI and disability from multiple sclerosis","volume":"346","author":"Brex","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.neurol.2011.06.005_bib0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00296-009-1292-x","article-title":"Anti-TNF therapies: a comprehensive analysis of adverse effects associated with immunosuppression","volume":"31","author":"Connor","year":"2011","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.neurol.2011.06.005_bib0015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/ibd.20406","article-title":"Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001\u20132002","volume":"14","author":"Cohen","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2011.06.005_bib0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-5728(96)00075-6","article-title":"Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain Barr\u00e9 syndrome","volume":"68","author":"Cr\u00e9ange","year":"1996","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.neurol.2011.06.005_bib0025","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.semarthrit.2010.06.004","article-title":"Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review","volume":"40","author":"Cruz Fern\u00e1ndez-Espartero","year":"2010","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.neurol.2011.06.005_bib0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cyto.2008.11.002","article-title":"Inflammatory demyelinating events following treatment with anti-tumor necrosis factor","volume":"45","author":"Fromont","year":"2009","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.neurol.2011.06.005_bib0035","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s10165-010-0339-x","article-title":"Development of myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis in a patient receiving treatment with anti-tumor necrosis factor-alpha","volume":"20","author":"Hirohama","year":"2010","journal-title":"Mod Rheumatol"},{"issue":"10","key":"10.1016\/j.neurol.2011.06.005_bib0040","first-page":"2287","article-title":"Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series","volume":"30","author":"Jarrett","year":"2003","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.neurol.2011.06.005_bib0045","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneurol.2009.11","article-title":"Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy","volume":"66","author":"Lozeron","year":"2009","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2011.06.005_bib0050","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1212\/WNL.56.5.666","article-title":"Serum levels of tumor necrosis factor-alpha in chronic inflammatory demyelinating polyneuropathy","volume":"56","author":"Misawa","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2011.06.005_bib0055","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2009.10.003","article-title":"BIOGEAS Study group. Autoimmune diseases induced by biological agents: a double-edged sword?","volume":"9","author":"Ramos-Casals","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.neurol.2011.06.005_bib0060","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1212\/WNL.57.10.1885","article-title":"Onset of multiple sclerosis associated with anti-TNF therapy","volume":"57","author":"Sicotte","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2011.06.005_bib0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mus.20924","article-title":"Tumor necrosis factor-alpha antagonists and neuropathy","volume":"37","author":"Stubgen","year":"2008","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.neurol.2011.06.005_bib0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1085-9489.2006.00065.x","article-title":"Circulating levels of cytokines and their modulation by intravenous immunoglobulin in multifocal motor neuropathy","volume":"11","author":"Terenghi","year":"2006","journal-title":"J Peripher Nerv Syst"},{"issue":"3","key":"10.1016\/j.neurol.2011.06.005_bib0075","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/WNL.53.3.457","article-title":"TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and the university of British Columbia MS\/MRI Analysis Group","volume":"53","author":"The Lenercept Multiple Sclerosis Study Group","year":"1999","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.neurol.2011.06.005_bib0080","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00415-010-5591-7","article-title":"Neurological adverse events associated with anti-tumor necrosis factor-alpha treatment","volume":"257","author":"Tristano","year":"2010","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2011.06.005_bib0085","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.47.6.1531","article-title":"Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2","volume":"47","author":"Van Oosten","year":"1996","journal-title":"Neurology"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378711003791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378711003791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T11:28:20Z","timestamp":1543404500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378711003791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0035378711003791"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2011.06.005","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}